Buy/Sell: Wall Street’s top 10 stock calls this week
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...
Barclays Downgrades Illumina (NASDAQ:ILMN) to Underweight
Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...
Why Illumina Inc. (ILMN) Went Down on Monday
However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...
Illumina cut to underweight by Barclays, China woes cited
Illumina (NASDAQ:ILMN) has been cut to underweight from equal weight by Barclays over concerns the company may be facing sanctions in China and risks to its 2025 and long-range guidance. "Given our ...
Barclays downgrades Illumina on China risks, competition
Barclays downgraded Illumina Inc (NASDAQ:ILMN) to "Underweight" given growing uncertainty in China, rising competition from Roche in the clinical market, and weaker-than-expected elasticity in ...
Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
Illumina downgraded to Underweight from Equal Weight at Barclays
Barclays downgraded Illumina (ILMN) to Underweight from Equal Weight with a price target of $100, down from $130. The firm sees greater risk to ...
GEN6d
StockWatch: Illumina Tumbles on Q4 Results, China Retaliation
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...